Walleye Capital’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-156
Closed -$8.97K 4419
2025
Q2
$8.97K Buy
+156
New +$12.5K ﹤0.01% 4320
2024
Q4
Sell
-868
Closed -$85.3K 4772
2024
Q3
$85.3K Sell
868
-1,000
-54% -$129K ﹤0.01% 4457
2024
Q2
$305K Sell
1,868
-164
-8% -$23.4K ﹤0.01% 3965
2024
Q1
$310K Buy
2,032
+1,824
+877% +$303K ﹤0.01% 3638
2023
Q4
$65.3K Buy
208
+92
+79% +$33.3K ﹤0.01% 4223
2023
Q3
$51.5K Buy
+116
New +$52.4K ﹤0.01% 4187

Other funds holding AGL

Walleye Capital's AGL Position: Q2 2026 in Review

Walleye Capital opened a new position in Agilon Health (AGL) in Q2 2026: 15,440 shares worth $1.65M. The stake represents 0.01% of the portfolio and ranks #1691 among its holdings. This is a return to the name: Walleye Capital previously reported a position in AGL as recently as Q3 2025.

Walleye Capital first reported a position in AGL in Q4 2021 and has held it in 8 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Walleye Capital held 15,440 shares of Agilon Health worth $1.65M as of Q2 2026.
  • Agilon Health was a new Walleye Capital position in Q2 2026.
  • Agilon Health made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1691 holding.
  • Walleye Capital first reported a position in Agilon Health in Q4 2021 and has held it in 8 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.